We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.8M
2
PG icon
Procter & Gamble
PG
+$24.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.6M
4
KEYS icon
Keysight
KEYS
+$23.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$21.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXN icon
51
Texas Instruments
TXN
$255B
$31M 0.39%
250,384
+41,072
+20% +$4.59M
ARQL
52
DELISTED
Arqule Inc
ARQL
$30.2M 0.38%
2,755,237
+1,353,056
+96% +$9.42M
SBUX icon
53
Starbucks
SBUX
$118B
$30M 0.37%
359,295
+124,833
+53% +$9.79M
SRPT icon
54
Sarepta Therapeutics
SRPT
$1.66B
$29.1M 0.36%
192,600
– –
ONC
55
BeOne Medicines Ltd
ONC
$33.8B
$28.8M 0.36%
233,752
+50,520
+28% +$6.41M
PTCT icon
56
PTC Therapeutics
PTCT
$6.37B
$28.7M 0.36%
640,523
+178,000
+38% +$7.03M
IBM icon
57
IBM
IBM
$202B
$28.3M 0.35%
202,650
+6,477
+3% +$851K
ALNY icon
58
Alnylam Pharmaceuticals
ALNY
$36.3B
$27.6M 0.34%
381,724
+97,023
+34% +$7.44M
PANW icon
59
Palo Alto Networks
PANW
$264B
$27.5M 0.34%
813,294
+358,218
+79% +$13.4M
TMO icon
60
Thermo Fisher Scientific
TMO
$211B
$27.3M 0.34%
93,500
+20,429
+28% +$5.63M
DHR icon
61
Danaher
DHR
$135B
$26.5M 0.33%
209,919
+11,341
+6% +$1.34M
ADI icon
62
Analog Devices
ADI
$181B
$26.4M 0.33%
234,637
+59,743
+34% +$6.47M
INTC icon
63
Intel
INTC
$466B
$26M 0.32%
496,113
-68,778
-12% -$3.41M
PRU icon
64
Prudential Financial
PRU
$41.7B
$25.9M 0.32%
238,677
-41,178
-15% -$4.1M
XOM icon
65
ExxonMobil
XOM
$651B
$25.9M 0.32%
338,825
-473,240
-58% -$36.6M
KEYS icon
66
Keysight
KEYS
$54.5B
$25.5M 0.32%
284,789
+273,244
+2,367% +$23.2M
SHW icon
67
Sherwin-Williams
SHW
$78.3B
$25.1M 0.31%
164,787
-12,720
-7% -$1.9M
UNP icon
68
Union Pacific
UNP
$183B
$25M 0.31%
148,269
-1,117
-0.7% -$191K
NEE icon
69
NextEra Energy
NEE
$187B
$24.7M 0.31%
449,080
+222,180
+98% +$10.9M
SLB icon
70
SLB Ltd
SLB
$77.8B
$24.6M 0.31%
621,099
+116,740
+23% +$4.71M
CAT icon
71
Caterpillar
CAT
$409B
$24.1M 0.3%
177,741
+96,494
+119% +$12.8M
NEM icon
72
Newmont
NEM
$98.2B
$23.9M 0.3%
623,435
+249,349
+67% +$8.43M
MMM icon
73
3M
MMM
$89B
$23.6M 0.29%
163,411
+17,297
+12% +$2.66M
RETA
74
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$23.4M 0.29%
249,200
– –
NBIX icon
75
Neurocrine Biosciences
NBIX
$17.7B
$22.5M 0.28%
267,669
-25,000
-9% -$2.05M
1 2
3
4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.